Neuren Pharmaceuticals Limited (NEU.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.4050+0.0050 (+0.36%)
At close: 4:10PM AEST
| Previous close | 1.4000 |
| Open | 1.3900 |
| Bid | 1.3900 x 1214500 |
| Ask | 1.4050 x 938700 |
| Day's range | 1.3900 - 1.4050 |
| 52-week range | 0.9950 - 1.8450 |
| Volume | 47,660 |
| Avg. volume | 120,490 |
| Market cap | 165.239M |
| Beta (5Y monthly) | 1.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0860 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.28 |
- Simply Wall St.
Neuren Pharmaceuticals (ASX:NEU) Is In A Strong Position To Grow Its Business
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Simply Wall St.
Here's What Neuren Pharmaceuticals Limited's (ASX:NEU) Shareholder Ownership Structure Looks Like
Every investor in Neuren Pharmaceuticals Limited (ASX:NEU) should be aware of the most powerful shareholder groups...
- Simply Wall St.
Independent Non-Executive Chairman Patrick Donald Davies Just Bought 24% More Shares In Neuren Pharmaceuticals Limited (ASX:NEU)
Whilst it may not be a huge deal, we thought it was good to see that the Neuren Pharmaceuticals Limited (ASX:NEU...
© 2021 Verizon Media. All rights reserved.
